MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20249056

October 16, 2024

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.3%(0.4ml: 1.2mg)

化学药品

October 16, 2024

Company Information

Applicant Company

吉林省延吉市高新技术开发区长白路389号

Manufacturing Company

吉林省延吉市高新技术开发区长白路389号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.